Compare AU
Compare VAS vs. EDOC
Compare shares and ETFs on the ASX that you can trade on Pearler.
Overview
When it comes to investing in the Australian stock market, Exchange-Traded Funds (ETFs) are a popular choice. Two well-known options in the Australian Securities Exchange (ASX) are the Vanguard Australian Shares Index ETF (VAS) and the BetaShares Digital Health and Telemedicine ETF (EDOC). In this comparison, we'll delve into these ETFs across various dimensions to help you make an informed investment decision.
Community Stats
VAS | EDOC | |
|---|---|---|
Popularity | High | Low |
Pearlers invested | 18,442 | 9 |
Median incremental investment | $1,003.13 | $705.01 |
Median investment frequency | Monthly | Monthly |
Median total investment | $2,889.32 | $471.50 |
Average age group | 26 - 35 | > 35 |
Key Summary
VAS | EDOC | |
|---|---|---|
Strategy | Vanguard Australian Shares Index ETF (ASX: VAS) seeks to track the performance of the ASX 300 index before account fees, expenses, and taxes. The index tracks the top 300 companies on the Australian Securities Exchange (ASX). | EDOC.AX was created on 2022-03-30 by BetaShares. The fund's investment portfolio concentrates primarily on health care equity. The investment objective of the BetaShares Digital Health and Telemedicine ETF is to provide an investment return that aims to track the performance of the NASDAQ CTA Global Digital Health Index (the Index), before taking into account fees and expenses. |
Top 3 holdings | BHP Group Ltd. (10.36 %) Commonwealth Bank of Australia (7.92 %) CSL Ltd. (5.76 %) | INSULET CORP (8.47 %) BOSTON SCIENTIFIC CORP (8.24 %) ABBOTT LABORATORIES (7.76 %) |
Top 3 industries | Financials (27.66 %) Materials (23.74 %) Health Care (8.77 %) | Health Care (75.06 %) Other (24.70 %) Consumer Staples (14.33 %) |
Top 3 countries | Australia (94.56 %) United States (3.02 %) New Zealand (1.65 %) | United States (77.51 %) China (13.32 %) Japan (4.67 %) |
Management fee | 0.07 % | 0.67 % |
Key Summary
VAS | EDOC | |
|---|---|---|
Issuer | Vanguard | BetaShares |
Tracking index | S&P/ASX 300 Index - AUD | Nasdaq CTA Global Digital Health Index - AUD - Benchmark TR Net |
Asset class | ETF | ETF |
Management fee | 0.07 % | 0.67 % |
Price | $103.19 | $10.25 |
Size | N/A | $1.658 million |
10Y return | 56.04 % | N/A |
Annual distribution yield (5Y) | 5.52 % | - % |
Market | ASX | ASX |
First listed date | 08/05/2009 | 29/03/2022 |
Purchase fee | $6.50 | $6.50 |
Community Stats
VAS | EDOC | |
|---|---|---|
Popularity | High | Low |
Pearlers invested | 18,442 | 9 |
Median incremental investment | $1,003.13 | $705.01 |
Median investment frequency | Monthly | Monthly |
Median total investment | $2,889.32 | $471.50 |
Average age group | 26 - 35 | > 35 |
Pros and Cons
VAS | EDOC | |
|---|---|---|
Pros |
|
|
Cons |
|
|
VAS | EDOC |
|---|---|
Higher exposure to AU market | Lower exposure to AU market |
Lower exposure to US market | Higher exposure to US market |
Lower management fee | Higher management fee |
Higher price growth | Lower price growth |
Higher distribution yield | Lower distribution yield |